- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00949078 | Completed Has Results |
Omalizumab in the Treatment of Peanut Allergy |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
51 | All | 18 Years to 50 Years (Adult) | NCT00949078 | NA_00026397 1U19AI070345 |
July 2009 | August 2011 | August 2011 | July 30, 2009 | July 12, 2017 | July 12, 2017 |
|
|
2 | NCT00429429 | Completed | Immunotherapy for Peanut Allergy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
7 | All | 6 Years to 35 Years (Child, Adult) | NCT00429429 | 1R21AT002557-02 | April 2006 | May 2011 | May 2011 | January 31, 2007 | June 20, 2016 |
|